MentionFox
Home › funding signals › ABVC BIOPHARMA, INC.
Form D · on the record

ABVC BIOPHARMA — $3.39M Form D filing, November 2026

Before you sell to, join or invest in ABVC BIOPHARMA, INC.

MentionFox check on ABVC BIOPHARMA, INC.: only 1 source on file so far (checked 13 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/abvc-biopharma-inc-form-d-118072

Check ABVC BIOPHARMA, INC. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about ABVC BIOPHARMA, INC.?

ABVC BIOPHARMA, INC. filed a Form D with the Securities and Exchange Commission on 2026-11-10.

ABVC BIOPHARMA, INC. filed a Form D notice of an exempt securities offering with the SEC on November 10, 2026. The filing reports $3.39M sold. Its industry group is Biotechnology. It names Uttam Patil (Executive Officer), Eugene Jiang (Executive Officer, Director), Tsung-Shann Jiang (Executive Officer, Director) (SEC Form D, November 10, 2026).

Sell to companies like ABVC BIOPHARMA, INC? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

ABVC BIOPHARMA, INC. raised on Nov 10. 88 companies raised this week, 1 had other signals.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

fal - Features & Labels, Inc.$1BAI and software
fal - Features & Labels, Inc.$350MAI and software
SIERRA INTERNATIONAL NETWORK INC$300MAI and software
Zai Lab Ltd$250MBiotech
Databento Inc.$100MAI and software
Check one company free All companies that raised this week

Selling to Abvc Biopharma, Inc.? See who runs it and how to reach them, plus this week's 84 other newly funded companies.

Is this your company?

Key facts

Run the free check on ABVC BIOPHARMA, INC. →

ABVC BIOPHARMA, INC.

New Form D on file · 2026-11-10 · the record

$3.39M
raise on the record
D
filing
9
investors in
CALIFORNIA
based
Open the record →

What the record says

FilingForm D
Filed2026-11-10
Industry groupBiotechnology
Entity typeCorporation
Incorporated inNEVADA
BasedFREMONT, CALIFORNIA
CIK1173313
Accession0001213900-26-118072

Pitching, partnering or investing alongside them? See who really runs and owns ABVC BIOPHARMA, INC.

Free to see. No signup.

What do you want to do with ABVC BIOPHARMA, INC.?

Get the full cited report on ABVC BIOPHARMA, INC.

What the filing shows about ABVC BIOPHARMA, INC.

  • 9 investors had already put money in when it filed.
  • The filing names 12 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on ABVC BIOPHARMA, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Just raised? Your investors will ask for updates.

The weeks after a raise are when investors, other founders and press look ABVC BIOPHARMA, INC. up. FoxPlug is your startup's chief of staff: it reads your whole stack and tells you what to fix, what to say and what to skip, for founders shipping with Claude Code, Codex or Cursor. It drafts your monthly investor update from your real numbers, and its free tools need no account. GetFoxChat puts an AI operator on ABVC BIOPHARMA, INC.'s own site, named as you like, so the visitors this record sends you don't read one page and leave.

Who the filing names, and in what role

The filing gives ABVC BIOPHARMA, INC.'s address as 44370 Old Warm Springs Blvd, Fremont, CA 94538.

What the filing says

  • Offered: $3,387,500. Sold: $3,387,500. Left to sell: nothing, all of it is sold. (filing)
  • Investors: 9 had already invested. (filing)
  • Date of first sale: October 30, 2026. (filing)
  • Types of securities: Debt. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)
  • On the amounts offered and sold: the filing adds “The amounts reported reflect the aggregate purchase price of $3,387,500 paid for senior convertible promissory notes with an aggregate principal amount of $4,106,060, issued at a 17.5% original issue discount.” (filing)
  • On sales commissions and finders' fees: the filing adds “WallachBeth Capital, LLC acted as exclusive placement agent for the private placement. The Company paid the placement agent a cash fee equal to 7% of the gross proceeds and reimbursed the placement agent for accountable expenses of $65,000.” (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on ABVC BIOPHARMA, INC. See pricing

Is ABVC BIOPHARMA, INC. a real, registered company?

ABVC BIOPHARMA, INC. is a registered filer with the SEC (CIK 1173313) and has filed since 2023-03-02. 3 filings are on record, the latest on 2026-11-10.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs ABVC BIOPHARMA, INC.?

ABVC BIOPHARMA, INC.'s Form D of 2026-11-10 names Uttam Patil, Eugene Jiang, Tsung-Shann Jiang and 9 more as its officers, directors or promoters.

How much has ABVC BIOPHARMA, INC. raised?

Its new offerings report $7.31M sold across 3 offerings, as its own filings state.

Filing history · 3 filings on this registrant
Form D · 2023-03-02 · $3.17MForm D · 2024-05-28 · $750KForm D · 2026-11-10 · $3.39M · this page 2023-03-02 2026-11-10

Each marker is one filing. The larger marker is the filing this page is about.

Biotechnology · by week
This raise, $3.39M, filed week of Nov 9

Trailing twelve months. 757 filings in Biotechnology, totalled by week. The dot is this raise, $3.39M, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on ABVC BIOPHARMA, INC.?

What the filing shows about ABVC BIOPHARMA, INC.

  • 9 investors had already put money in when it filed.
  • The filing names 12 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on ABVC BIOPHARMA, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on ABVC BIOPHARMA, INC. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Sourced from the filing index on sec.gov.

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for ABVC BIOPHARMA, INC.. With no account yet, you sign up free and land on the result.

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

ABVC BIOPHARMA, INC.: Raised $3.39M, Form D filed 2026-11-10
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/abvc-biopharma-inc-form-d-118072
Last updated 2026-11-13
Primary record: SEC filing 1 · SEC filing 2
ABVC BIOPHARMA raised $3.39M — SEC Form D filing, November 2026. MentionFox, 2026-11-13. https://mentionfox.com/funding/abvc-biopharma-inc-form-d-118072